Mitchell P. Kopin 13D and 13G filings for Petros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 07:54 am Purchase | 2021-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Mitchell P. Kopin | 6,407 7.200% | 4,091 (+176.62%) | Filing |
| 2021-01-29 06:14 am Unchanged | 2020-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Mitchell P. Kopin | 2,316 5.700% | 0 (Unchanged) | Filing |
| 2021-01-20 4:26 pm Purchase | 2020-12-01 | 13G | Petros Pharmaceuticals, Inc. PTPI | Mitchell P. Kopin | 2,316 5.700% | 2,316 (New Position) | Filing |